InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Henson Heidi. Insider active across 3 companies, notably LISATA THERAPEUTICS, INC.. In total, 6 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €95k. History available since 9 January 2023. The latest transaction was disclosed on 9 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
HENSON HEIDI is a declarant linked to LISATA THERAPEUTICS, INC., Perspective Therapeutics, Inc. and Pardes Biosciences, INC., with the role of Director at the first two and Chief Financial Officer at Pardes Biosciences, INC. The record shows 6 filings in total, and across the sampled recent filings from 2023-01-11 to 2026-01-13, buys amount to EUR 95144 and sells to EUR 0, with Attribution as the modal transaction nature.